Product description

The COVID-19 treatment drug molnupiravir shortens the recovery period due to early administration. The general name 'Molnupiravir', which could be kept from using ventilators low, is derived from the god of Norse mythology, Myeongnil, the hammer of Tol, meaning that the medicine knocks down the virus like an intense attack from the brain god.

Molnupiravir is a product authorized by the FDA for emergency use to treat COVID-19. It is used by adults 18 and older who have mild to severe symptoms and have not been hospitalized within 5 days.

Ingredients/Content

1 tablet Molnupiravir 200mg 

Usage/Capacity

The Molnupiravir effect is to administer 800 mg of molnupiravir once to the patient twice a day, orally for 5 days. 

Efficacy/Effectiveness

Initiate administration quickly after symptoms of infectious diseases caused by SARS-CoV-2 are developed. 

In clinical trials, data supporting efficacy were not obtained in patients who started administration after the 6th day of symptom onset. 

Anyone over the age of 18 who has a risk factor for seriousness, etc., who thinks molnupiravir needs to be administered ↓ 

·60 years of age or older

·a cancer patient 

·chronic kidney disease

·chronic obstructive pulmonary disease 

·If you have a severe liver disease such as heart failure, coronary artery disease or cardiomyopathy, diabetes, poor control HIV infection, AIDS, cirrhosis, and other chronic diseases, please contact your specialist doctor. 

Precautions for Use

·Anyone who has a history of hypersensitivity to the ingredients of this product 

·a pregnant woman or a woman who may be pregnant 

Packaging Size 

40 Capsules (1 box)

Manufacturer 

Asher pharmaceuticals